Skip to content
10-Q

Quarterly Report

GREEN VISION BIOTECHNOLOGY CORP.

0001640334-21-002056

← back to feed
Filed
Aug 30, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Aug 23, 2021 160.79M sh
Current Liabilities Q3 2020 · Sep 30, 2020 $10.11M
Current Liabilities Q3 2020 · Dec 31, 2019 $9.97M
Total Liabilities Q3 2020 · Sep 30, 2020 $10.11M
Total Liabilities Q3 2020 · Dec 31, 2019 $9.97M
Current Assets Q3 2020 · Sep 30, 2020 $88.63K
Current Assets Q3 2020 · Dec 31, 2019 $98.96K
Total Assets Q3 2020 · Sep 30, 2020 $3M
Total Assets Q3 2020 · Dec 31, 2019 $3.06M
Shares Diluted Q3 2020 · Sep 30, 2019 160.79M sh
Operating Cash Flow Q3 2020 · Sep 30, 2019 $175.37K
Stockholders Equity Q3 2020 · Sep 30, 2019 −$6.77M
Stockholders Equity Q3 2020 · Jun 30, 2019 −$6.61M
Stockholders Equity Q3 2020 · Mar 31, 2019 −$6.49M
Stockholders Equity Q3 2020 · Dec 31, 2018 −$6.41M
Net Income Q3 2020 · Sep 30, 2019 −$156.64K
Net Income Q3 2020 · Jun 30, 2019 −$123.49K
Net Income Q3 2020 · Mar 31, 2019 −$75.69K
Operating Income Q3 2020 · Sep 30, 2019 −$158.28K
Operating Income Q3 2020 · Sep 30, 2019 −$407.94K
Gross Profit Q3 2020 · Sep 30, 2019 $3.82K
Gross Profit Q3 2020 · Sep 30, 2019 $10.86K
Revenue Q3 2020 · Sep 30, 2019 $6.13K
Revenue Q3 2020 · Sep 30, 2019 $77.4K